The agenda of the Republic of Poland on February 7 includes:
Preparation of a position on drug evaluation:
Imbruvica (ibrutinibum) under the drug scheme: B.92. "Treatmen...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
